U.S. News & World Report 2025–2026 recognizes Baptist Health South Florida as a High Performing Center for Prostate Cancer Surgery
U.S. News & World Report has recognized Baptist Health South Florida as a High Performing center for Prostate Cancer Surgery for 2025–2026 — a program led by Dr. Murugesan Manoharan, one of the world's leading robotic prostate cancer surgeons.
Leading this program is Dr. Murugesan Manoharan, Chair of Urology at Baptist Health South Florida and one of the globally recognized leaders in robotic prostate cancer surgery. A high-volume robotic surgeon with more than 30 years of experience in urologic oncology and performed thousands of robotic prostatectomy surgeries, Dr. Manoharan has dedicated his career to advancing the surgical treatment of prostate cancer while maintaining a strong focus on quality-of-life outcomes, including urinary continence and sexual function.
In addition to robotic prostatectomy, Dr. Manoharan offers advanced minimally invasive treatment options for localized prostate cancer, including High-Intensity Focused Ultrasound (HIFU) and NanoKnife® irreversible electroporation. These technologies expand treatment options for carefully selected patients seeking effective cancer control with minimal disruption to their quality of life.
Dr. Manoharan has earned national and international recognition for his contributions to prostate cancer treatment and the advancement of robotic surgery. His research and surgical innovations in robotic prostatectomy have been published in leading urologic journals, and several of his techniques have been adopted by surgeons around the world.
As Chair of Urology at Baptist Health South Florida, he has played a pivotal role in building one of the region's most recognized prostate cancer programs. Under his leadership, Baptist Health South Florida has become a destination center for advanced robotic prostate cancer surgery, attracting patients from across South Florida, the United States, and internationally. The program is known for its high surgical volumes, multidisciplinary approach, and commitment to delivering state-of-the-art prostate cancer care.
Today, Dr. Manoharan continues to lead advancements in prostate cancer treatment, combining surgical expertise, clinical research, and visionary leadership to improve outcomes for men diagnosed with prostate cancer.
